guizhi fuling capsule has completed the iib phase of clinical trials in the united states in 2015
date:2021.07.15

guizhi fuling capsule as the first batch of products recommended by the chinese government for drug registration by the us fda, has completed the second phase of clinical trials in the united states, and the third phase of clinical trials will be launched soon.




contact us
get in touch today
contact us
网站地图